{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:58:35Z","timestamp":1790632715580,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.freeradbiomed.2018.06.025","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:27:51Z","timestamp":1530127671000},"page":"248-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Misdistribution of iron and oxidative stress in chronic kidney disease"],"prefix":"10.1016","volume":"133","author":[{"given":"Takeshi","family":"Nakanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kuragano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Nanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000014479","article-title":"Inflammatory and atherosclerotic interactions in the depleted uremic patient","volume":"19","author":"Stenvinkel","year":"2001","journal-title":"Blood Purif."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/abbi.2001.2671","article-title":"The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age","volume":"397","author":"Atamna","year":"2002","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000320733","article-title":"Importance of ferritin for optimizing anemia therapy in chronic kidney disease","volume":"32","author":"Nakanishi","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib6","doi-asserted-by":"crossref","unstructured":"I.C. Macdougall, A.J. Bircher, K.U. Eckardt, G.T. Obrador, C.A. Pollock, P. Stenvinkel, D.W. Swinkels, C. Wanner, G. Weiss, G.M. Chertow, Conference Participants.: Iron management in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2016.;89:28-39.","DOI":"10.1016\/j.kint.2015.10.002"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.ajkd.2004.02.016","article-title":"Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis","volume":"43","author":"Otaki","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib8","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/01.ATV.0000190610.63878.20","article-title":"Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells","volume":"25","author":"Nanami","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1744-9987.2010.00824.x","article-title":"Pathological role of aminolevulinate in uremic patients","volume":"15","author":"Hasuike","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10157-012-0737-9","article-title":"The mitochondrial protein frataxin is downregulated in hemodialysis patients","volume":"17","author":"Hasuike","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib11","first-page":"5","article-title":"Iron, free radicals, and oxidative injury","volume":"35","author":"McCord","year":"1998","journal-title":"Semin Hematol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI118205","article-title":"Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation","volume":"96","author":"Kadiiska","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphar.2014.00176","article-title":"The IRP\/IRE system in vivo: insights from mouse models","volume":"5","author":"Wilkinson","year":"2014","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ajcn\/87.5.1374","article-title":"Pathways underlying iron accumulation in human nonalcoholic fatty liver disease","volume":"87","author":"Aigner","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib17","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","article-title":"Cytokine-mediated regulation of iron transport in human monocytic cells","volume":"101","author":"Ludwiczek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000337742","article-title":"High levels of tumor necrosis factor-\u03b1 downregulate antimicrobial iron transport protein, Nramp1, in chronic hemodialysis patients: a key factor for infection risk","volume":"35","author":"Moriguchi","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000312381","article-title":"Determinants of hepcidin in patients on maintenance Hemodialysis: role of inflammation","volume":"31","author":"Kuragano","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3324\/haematol.2013.099481","article-title":"Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats","volume":"99","author":"Theurl","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib23","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/ndt\/gfr410","article-title":"Hepcidin: another culprit for complications in patients with chronic kidney disease?","volume":"26","author":"Nakanishi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000380967","article-title":"Dysregulated iron metabolism in patients on hemodialysis","volume":"185","author":"Nakanishi","year":"2015","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1447-0594.2009.00528.x","article-title":"Associations between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients","volume":"9","author":"Aoki","year":"2009","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib26","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","article-title":"Hepcidin as well as TNF-\u03b1 are significant predictors of arterial stiffness in patients on maintenance hemodialysis","volume":"26","author":"Kuragano","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41598-017-19092-1","article-title":"Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with\/without TNF-alpha","volume":"8","author":"Kawada","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib28","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1097\/01.ASN.0000092138.65211.71","article-title":"Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study","volume":"14","author":"Jurkovitz","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib29","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/ndt\/gfv268","article-title":"Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited","volume":"31","author":"Nakanishi","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10157-012-0694-3","article-title":"Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?","volume":"16","author":"Nakanishi","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib31","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib33","doi-asserted-by":"crossref","first-page":"e0147328","DOI":"10.1371\/journal.pone.0147328","article-title":"ESA hyporesponsiveness is associated with adverse events in maintenance hemodialysis (MHD) patients, but not with iron storage","volume":"11","author":"Kuragano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000351175","article-title":"Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease","volume":"37","author":"McCullough","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/j.ajkd.2013.10.006","article-title":"Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later","volume":"62","author":"Weiner","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.ajkd.2013.10.052","article-title":"Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion","volume":"63","author":"Collins","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1053\/j.ajkd.2013.09.006","article-title":"The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle","volume":"62","author":"Fuller","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl.2","key":"10.1016\/j.freeradbiomed.2018.06.025_bib38","first-page":"279","article-title":"Clinical practice guideline for anemia in chronic kidney disease","author":"KDIGO","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12185-008-0119-y","article-title":"Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes","volume":"88","author":"Suzuki","year":"2008","journal-title":"Int J. Hematol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib40","doi-asserted-by":"crossref","first-page":"F877","DOI":"10.1152\/ajprenal.00089.2016","article-title":"Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease","volume":"311","author":"Akchurin","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib41","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3324\/haematol.2016.150433","article-title":"Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model","volume":"102","author":"Hanudel","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SHK.0000000000000886","article-title":"In a mouse model of sepsis, hepcidin ablation ameliorates anemia more effectively Than iron and erythropoietin treatment","volume":"48","author":"Khorramian","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.nutr.24.012003.132306","article-title":"New insights into erythropoiesis: the roles of folate, vitamin B12, and iron","volume":"24","author":"Koury","year":"2004","journal-title":"Annu Rev. Nutr."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib44","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ndt\/gfs584","article-title":"A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib45","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib46","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2014-06-584607","article-title":"Erythroferrone contributes to recovery from anemia of inflammation","volume":"124","author":"Kautz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/1744-9987.12161","article-title":"Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study","volume":"18","author":"Kakimoto-Shino","year":"2014","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/1744-9987.12164","article-title":"Comparison of 2-week versus 4-week dosing intervals of epoetin beta pegol on erythropoiesis and iron metabolism in hemodialysis patients","volume":"18","author":"Morikami","year":"2014","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.12067","article-title":"Greater potency of darbepoetin-\u03b1 than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients","volume":"90","author":"Shoji","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients With CKD","volume":"69","author":"Gupta","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib52","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1111\/jnc.12303","article-title":"Mitochondrial pathophysiology in Friedreich's ataxia","volume":"126","author":"Gonz\u00e1lez-Cabo","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yjmcc.2012.05.014","article-title":"Transition metals and mitochondrial metabolism in the heart","volume":"55","author":"Rines","year":"2013","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","article-title":"The role of iron in mitochondrial function","volume":"1790","author":"Levi","year":"2009","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/BJ20130079","article-title":"Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia","volume":"453","author":"Lane","year":"2013","journal-title":"Biochem J."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/hmg\/ddi461","article-title":"Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity","volume":"15","author":"Gakh","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.1098991","article-title":"Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity","volume":"305","author":"Bulteau","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-510X(02)00432-X","article-title":"Frataxin and frataxin deficiency in Friedreich's ataxia","volume":"207","author":"Wilson","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/ars.2009.3015","article-title":"Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities","volume":"13","author":"Santos","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib60","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1096\/fj.09-143222","article-title":"Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question","volume":"24","author":"Armstrong","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clinbiochem.2015.11.008","article-title":"Frataxin expression in reticulocytes of non-splenectomized and splenectomized patients with HbE-\u03b2-thalassaemia","volume":"49","author":"Suebpeng","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V89.1.1","article-title":"Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells","volume":"89","author":"Ponka","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.abb.2004.09.030","article-title":"Mitochondrial and nuclear DNA damage induced by 5-aminolevulinic acid","volume":"432","author":"Onuki","year":"2004","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/cs0720103","article-title":"Delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects","volume":"72","author":"Gorchein","year":"1987","journal-title":"Clin. Sci. (Lond.)."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopha.2007.10.017","article-title":"The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients","volume":"62","author":"Valentini","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0003-9861(02)00633-1","article-title":"Oxidative damage to ferritin by 5-aminolevulinic acid","volume":"409","author":"Rocha","year":"2003","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0005-2728(05)80072-6","article-title":"Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning","volume":"1056","author":"Hermes-Lima","year":"1991","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib68","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/abbi.1995.1080","article-title":"5-Aminolevulinic acid induces iron release from ferritin","volume":"316","author":"Oteiza","year":"1995","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib69","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/bj3280827","article-title":"Haem precursor delta-aminolaevulinic acid induces activation of the cytosolic iron regulatory protein 1","volume":"328","author":"Carvalho","year":"1997","journal-title":"Biochem J."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib70","first-page":"838","article-title":"Heme metabolism and erythropoiesis in abnormal iron states: role of delta-aminolevulinic acid synthase and heme oxygenase","volume":"13","author":"Abraham","year":"1985","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0167-4838(86)90238-4","article-title":"Effects of iron deficiency and chronic iron overloading on mitochondrial heme biosynthetic enzymes in rat liver","volume":"870","author":"Abraham","year":"1986","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib72","first-page":"95","article-title":"Reduced aminolevulinic dehydrase activity with increased blood porphyrins in experimental chronic renal failure","volume":"5","author":"Fontanellas","year":"1997","journal-title":"Exp. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0899-9007(03)00065-0","article-title":"Influence of dietary selenium supplementation and exercise on thiol-containing enzymes in mice","volume":"19","author":"Soares","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib74","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biopha.2006.12.007","article-title":"Oxidative stress and delta-ALA-D activity in chronic renal failure patients","volume":"61","author":"da Silva","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib75","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1681\/ASN.V75774","article-title":"Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis","volume":"7","author":"Fontanellas","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/ajkd.2002.33912","article-title":"Erythrocyte aminolevulinate dehydratase activity as a lead marker in patients with chronic renal failure","volume":"40","author":"Fontanellas","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib77","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1525-139X.2007.00334.x","article-title":"Role of leptin in reverse epidemiology in chronic kidney disease","volume":"20","author":"Scholze","year":"2007","journal-title":"Semin Dial."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: a narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2014.06.024","article-title":"Leptin as an uremic toxin: deleterious role of leptin in chronic kidney disease","volume":"105","author":"Alix","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib80","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib81","doi-asserted-by":"crossref","first-page":"e11376","DOI":"10.1371\/journal.pone.0011376","article-title":"Hyperleptinemia is required for the development of leptin resistance","volume":"5","author":"Knight","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib82","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2017.11.103","article-title":"Interplay of adipocyte and hepatocyte: leptin upregulates hepcidin","volume":"495","author":"Yamamoto","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib83","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ndt\/12.7.1321","article-title":"Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure","volume":"12","author":"Stenvinkel","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib84","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/ki.1997.269","article-title":"Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients","volume":"51","author":"Sharma","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib85","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.09961110","article-title":"Committee of renal data Registry, Japanese Society for dialysis therapy.: elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients","volume":"6","author":"Shoji","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib86","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","article-title":"A malnutrition- inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients","volume":"38","author":"Kalantar-Zadeh","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib87","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21177","article-title":"Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin","volume":"62","author":"Boesch","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.freeradbiomed.2018.06.025_bib89","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1111\/jnc.12301","article-title":"Erythropoietin in Friedreich ataxia","volume":"126","author":"Mariotti","year":"2013","journal-title":"J. Neurochem."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584918311158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584918311158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:03:58Z","timestamp":1760205838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584918311158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":89,"alternative-id":["S0891584918311158"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.025","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misdistribution of iron and oxidative stress in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}